BCLI Stock Quote Price and Forecast - CNN

BCLI Stock  USD 1.51  0.09  5.63%   
Under 63% of Brainstorm Cell's investor base is looking to short. The analysis of the overall investor sentiment regarding Brainstorm Cell Therapeutics suggests that many traders are alarmed. Brainstorm Cell's investing sentiment shows overall attitude of investors towards Brainstorm Cell Therapeutics.
  
BCLI Stock Quote Price and Forecast CNN

Read at news.google.com
Google News at Macroaxis
  

Brainstorm Cell Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Brainstorm Cell can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Brainstorm Cell Fundamental Analysis

We analyze Brainstorm Cell's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Brainstorm Cell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Brainstorm Cell based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Cash Flow From Operations

Cash Flow From Operations Comparative Analysis

Brainstorm Cell is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.

Brainstorm Cell Ther Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Brainstorm Cell stock to make a market-neutral strategy. Peer analysis of Brainstorm Cell could also be used in its relative valuation, which is a method of valuing Brainstorm Cell by comparing valuation metrics with similar companies.

Peers

Brainstorm Cell Related Equities

TRVITrevi Therapeutics   44.58   
0%
100.0%
PASGPassage Bio   2.63   
0%
5.0%
INZYInozyme Pharma   0.68   
0%
1.0%
CRVSCorvus Pharmaceuticals   0.37   
1.0%
0%
PLXProtalix Biotherapeutics   1.64   
3.0%
0%
TERNTerns Pharmaceuticals   1.64   
3.0%
0%
CELCCelcuity LLC   1.87   
4.0%
0%
HCWBHCW Biologics   2.50   
5.0%
0%
DAWNDay One   2.66   
5.0%
0%
MREOMereo BioPharma   3.37   
7.0%
0%
CKPTCheckpoint Therapeutics   4.52   
10.0%
0%
ANTXAN2 Therapeutics   4.52   
10.0%
0%
EWTXEdgewise Therapeutics   5.54   
12.0%
0%
CNTBConnect Biopharma   6.50   
14.0%
0%
ALDXAldeyra   6.70   
15.0%
0%
GBIOGeneration Bio   7.03   
15.0%
0%
HOWLWerewolf Therapeutics   7.57   
16.0%
0%
CUECue Biopharma   7.89   
17.0%
0%
CCCCC4 Therapeutics   8.28   
18.0%
0%
GRIGRI Bio   8.92   
20.0%
0%
BCABBioatla   11.18   
25.0%
0%
XFORX4 Pharmaceuticals   21.05   
47.0%
0%

Complementary Tools for Brainstorm Stock analysis

When running Brainstorm Cell's price analysis, check to measure Brainstorm Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainstorm Cell is operating at the current time. Most of Brainstorm Cell's value examination focuses on studying past and present price action to predict the probability of Brainstorm Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainstorm Cell's price. Additionally, you may evaluate how the addition of Brainstorm Cell to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Fundamental Analysis
View fundamental data based on most recent published financial statements
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios